Study on the Factors Influencing the Medical Insurance Settlement Payment Rate Under the DIP Payment————Empirical Analysis Based on G City

China Health Insurance ›› 2025, Vol. 0 ›› Issue (4) : 90-95.

China Health Insurance ›› 2025, Vol. 0 ›› Issue (4) : 90-95. DOI: 10.19546/j.issn.1674-3830.2025.4.012
Medical Viewpoint

Study on the Factors Influencing the Medical Insurance Settlement Payment Rate Under the DIP Payment————Empirical Analysis Based on G City

Author information +
History +

Abstract

Objective: The paper analyzes the current status and influencing factors of the medical insurance settlement payment rate under the DIP payment system, providing a basis for improving the DIP payment policy, optimizing internal operations in medical institutions, and ensuring reasonable compensation. Methods: Based on the DIP settlement data from 158 medical institutions in G City from January to March 2024, multiple linear regression analysis was used to investigate the factors affecting the medical insurance settlement payment rate. Results: The empirical results show that lower hospitalization costs, shorter hospital stays were associated with higher medical insurance settlement payment rate (P<0.05). Medical insurance settlement payment rates were significantly lower for tertiary medical institutions and core diseases (P<0.05). The medical insurance settlement payment rate of employees' medical insurance is higher than that of residents' medical insurance, and non-conservative treatment is higher than that of conservative treatment (P<0.05). Conclusion: Healthcare security institutions should optimize payment policy design, dynamically adjust disease category values, improve the mechanism of special case negotiation, enhance the fairness and scientificity of payments, and improve the dynamic adjustment mechanism for the fundraising of the residents' medical insurance fund and benefit standards, ensuring the stable operation of the fund in the long term. Medical institutions should implement refined management, optimize cost accounting, strengthen internal supervision and management, and enhance their adaptability to the DIP payment system reform.

Key words

DIP / Diagnosis-Intervention Packet / medical insurance settlement payment rate / medical insurance payment method reform

Cite this article

Download Citations
Study on the Factors Influencing the Medical Insurance Settlement Payment Rate Under the DIP Payment————Empirical Analysis Based on G City[J]. China Health Insurance. 2025, 0(4): 90-95 https://doi.org/10.19546/j.issn.1674-3830.2025.4.012

References

[1] 国家医疗保障局办公室.关于印发按病组和病种分值付费2.0版分组方案并深入推进相关工作的通知[EB/OL].(2024-07-17)[2025-01-16].https://www.gov.cn/zhengce/zhengceku/202407/content_6964136.htm.
[2] 李立伟.医保支付方式改革对医院财务管理的影响探究[J].财经界,2021(32):139-140.
[3] 赵梦园,林坤河,熊英贝,等.DIP支付方式下医疗机构医保支付率及影响因素分析[J].中国卫生政策研究,2024,17(06):40-46.
[4] 封娟.DIP医保支付方式改革对基层医院的控费效果评价研究[J].医学信息,2024,37(22):5-8.
[5] 毛玫涵,郝嘉琦,祁瑞.按病种分值付费改革下试点县级医疗机构的运营现况分析[J].华西医学,2024,39(12):1874-1879.
[6] 王颖,何瑞星,柏红.宿迁市某医院实施DIP付费方式的效果评价[J].江苏卫生事业管理,2022,33(12):1664-1666.
[7] 周琳,刘婷,卢玉兰.DIP付费下医院可控结余影响因素分析——以广东省东莞市某三甲医院为例[J].中国医疗保险,2024(03):89-94.
[8] 魏喻周,马倩,张格祥,等.兰州市骨折患者直接医疗费用负担研究[J].中国社区医师,2022,38(34):155-157.
[9] 吴月苹,李红娟,张亮,等.医保DIP改革与医疗服务供给的伦理思考:冲突与对策[J].医学与哲学,2023,44(19):17-19.
[10] 吴唯倩,曾雁冰.2009—2022年我国基本医保收支结存状况及风险警戒分析[J].中国卫生经济,2024,43(1):34-37.
[11] 张文君.河北省城乡居民基本医疗保险基金风险防控研究[D].石家庄:河北经贸大学,2022.
[12] 戴文瑜,白丽萍.推进城乡居民医保制度有效整合的策略思考[J].中国市场,2019(15):29-31.
[13] 朱晓丽,王玙珩.我国部分省份基本医保省级统筹的政策内容比较分析与优化[J].中国医疗保险,2024(10):29-34.
[14] 朱铭来,欧菁菁.我国居民医保筹资与待遇衔接机制的公平性思考[J].中国医疗保险,2024(02):47-59.
[15] 黄小君,金新政,叶云,等.省级统筹政策视角下医保基金运行预测研究[J].卫生软科学,2023,37(06):75-80.
[16] 陈菁,王海国.DIP付费模式下妇幼保健机构绩效考核体系构建——以湖北省某妇幼保健院为例[J].中国医疗保险,2023(06):77-82.
[17] 陈志军,包维晔,沈思远,等.基于临床路径的儿科病种成本收益研究[J].卫生经济研究,2023,40(08):49-52.
[18] 邵雪丽,李建军,史晓川,等.公立医院DIP病种成本核算与效益分析的实践探索[J].卫生经济研究,2024,41(12):60-64.
[19] 蹇思慧,陈晓雯.肝脏手术病例的DRG分组效果及费用影响因素研究——以福建某三甲医院为例[J].卫生软科学,2024,38(01):74-78.
[20] 张映钰,乐煦,曾茜.广州市基于大数据的病种分值付费实施路径与成效[J].中国医疗保险,2020(09):47-51.
[21] 中共中央,国务院.关于促进中医药传承创新发展的意见[EB/OL].(2019-10-26)[2025-01-16].https://www.gov.cn/zhengce/2019-10/26/content_5445336.htm.
[22] 国家中医药管理局,国家卫生健康委员会.关于印发《中医病证分类与代码》和《中医临床诊疗术语》的通知[EB/OL].(2020-11-16)[2025-01-16].https://www.gov.cn/zhengce/zhengceku/2020-11/24/content_5563703.htm.
[23] 单红燕.DIP分值付费下公立医院建立多维度成本管控模式的思考[J].中国总会计师,2021(02):110-111.
[24] 游颖娟,熊娟,刘樱.单病种付费下阑尾炎患者费用分析[J].中国病案,2022,23(10):55-58.
[25] GLENNIE R A, URQUHART J C, KOTO P, et al.Microdiscectomy is more cost-effective than a 6-month nonsurgical care regimen for chronic radiculopathy[J].Clin Orthop Relat Res,2022,480(03):574-584.

Accesses

Citation

Detail

Sections
Recommended

/